These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31248771)

  • 1. l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophan.
    Hall C; Wolfe H; Wells A; Chien HC; Colas C; Schlessinger A; Giacomini KM; Thomas AA
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2254-2258. PubMed ID: 31248771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1).
    Ylikangas H; Malmioja K; Peura L; Gynther M; Nwachukwu EO; Leppänen J; Laine K; Rautio J; Lahtela-Kakkonen M; Huttunen KM; Poso A
    ChemMedChem; 2014 Dec; 9(12):2699-707. PubMed ID: 25205473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Prodrug Size and a Carbonyl Linker on l-Type Amino Acid Transporter 1-Targeted Cellular and Brain Uptake.
    Venteicher B; Merklin K; Ngo HX; Chien HC; Hutchinson K; Campbell J; Way H; Griffith J; Alvarado C; Chandra S; Hill E; Schlessinger A; Thomas AA
    ChemMedChem; 2021 Mar; 16(5):869-880. PubMed ID: 33230949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).
    Chien HC; Colas C; Finke K; Springer S; Stoner L; Zur AA; Venteicher B; Campbell J; Hall C; Flint A; Augustyn E; Hernandez C; Heeren N; Hansen L; Anthony A; Bauer J; Fotiadis D; Schlessinger A; Giacomini KM; Thomas AA
    J Med Chem; 2018 Aug; 61(16):7358-7373. PubMed ID: 30048132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Click chemistry inspired facile synthesis and bioevaluation of novel triazolyl analogs of Ludartin.
    Lone SH; Bhat KA; Majeed R; Hamid A; Khuroo MA
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1047-51. PubMed ID: 24484897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Evaluation of l-Tryptophan Derivatives as Inhibitors of the l-Type Amino Acid Transporter LAT1 (SLC7A5).
    Graff J; Müller J; Sadurní A; Rubin M; Canivete Cuissa IA; Keller C; Hartmann M; Singer S; Gertsch J; Altmann KH
    ChemMedChem; 2022 Sep; 17(17):e202200308. PubMed ID: 35895286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-Type amino acid transporter 1 (LAT1)-utilizing prodrugs are carrier-selective despite having low affinity for organic anion transporting polypeptides (OATPs).
    Huttunen J; Gynther M; Vellonen KS; Huttunen KM
    Int J Pharm; 2019 Nov; 571():118714. PubMed ID: 31610281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.
    Puris E; Gynther M; Huttunen J; Auriola S; Huttunen KM
    Eur J Pharm Sci; 2019 Mar; 129():99-109. PubMed ID: 30625368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-type amino acid transporter 1 utilizing prodrugs: How to achieve effective brain delivery and low systemic exposure of drugs.
    Puris E; Gynther M; Huttunen J; Petsalo A; Huttunen KM
    J Control Release; 2017 Sep; 261():93-104. PubMed ID: 28662899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary carbamate linker can facilitate the sustained release of dopamine from brain-targeted prodrug.
    Thiele NA; Kärkkäinen J; Sloan KB; Rautio J; Huttunen KM
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2856-2860. PubMed ID: 30055889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Selective and Slowly Reversible Inhibitor of l-Type Amino Acid Transporter 1 (LAT1) Potentiates Antiproliferative Drug Efficacy in Cancer Cells.
    Huttunen KM; Gynther M; Huttunen J; Puris E; Spicer JA; Denny WA
    J Med Chem; 2016 Jun; 59(12):5740-51. PubMed ID: 27253989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship study of compounds binding to large amino acid transporter 1 (LAT1) based on pharmacophore modeling and in situ rat brain perfusion.
    Ylikangas H; Peura L; Malmioja K; Leppänen J; Laine K; Poso A; Lahtela-Kakkonen M; Rautio J
    Eur J Pharm Sci; 2013 Feb; 48(3):523-31. PubMed ID: 23228412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.
    Zur AA; Chien HC; Augustyn E; Flint A; Heeren N; Finke K; Hernandez C; Hansen L; Miller S; Lin L; Giacomini KM; Colas C; Schlessinger A; Thomas AA
    Bioorg Med Chem Lett; 2016 Oct; 26(20):5000-5006. PubMed ID: 27624080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
    Peura L; Malmioja K; Laine K; Leppänen J; Gynther M; Isotalo A; Rautio J
    Mol Pharm; 2011 Oct; 8(5):1857-66. PubMed ID: 21770378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid synthesis of triazole-modified resveratrol analogues via click chemistry.
    Pagliai F; Pirali T; Del Grosso E; Di Brisco R; Tron GC; Sorba G; Genazzani AA
    J Med Chem; 2006 Jan; 49(2):467-70. PubMed ID: 16420033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia.
    Huttunen J; Peltokangas S; Gynther M; Natunen T; Hiltunen M; Auriola S; Ruponen M; Vellonen KS; Huttunen KM
    Sci Rep; 2019 Sep; 9(1):12860. PubMed ID: 31492955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting L-type amino acid transporter 1 for anticancer therapy: clinical impact from diagnostics to therapeutics.
    Jin SE; Jin HE; Hong SS
    Expert Opin Ther Targets; 2015; 19(10):1319-37. PubMed ID: 25968633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ynamide Click chemistry in development of triazole VEGFR2 TK modulators.
    Vojtičková M; Dobiaš J; Hanquet G; Addová G; Cetin-Atalay R; Yildirim DC; Boháč A
    Eur J Med Chem; 2015 Oct; 103():105-22. PubMed ID: 26344911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamine.
    Peura L; Malmioja K; Huttunen K; Leppänen J; Hämäläinen M; Forsberg MM; Gynther M; Rautio J; Laine K
    Pharm Res; 2013 Oct; 30(10):2523-37. PubMed ID: 24137801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid ester prodrugs conjugated to the α-carboxylic acid group do not display affinity for the L-type amino acid transporter 1 (LAT1).
    Rautio J; Kärkkäinen J; Huttunen KM; Gynther M
    Eur J Pharm Sci; 2015 Jan; 66():36-40. PubMed ID: 25305508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.